[Evaluation of results of radiotherapy and localized prostate cancer, Experiences at the Francois Baclesse Center 2000-2001].
The authors report the collegial activity performed during the first two years of François Baclesse Center existence. This experience results from the collaboration between Luxemburgish Urologists and technical and medical staff of the National Radiotherapy Center. 194 new prostate cancer cases have been recorded between 2000 and 2001. 98 of them have been treated by curative three-dimensional conformal radiotherapy. For the 72 Gy level of dose, ilio-obturator curage has been performed in 50% of the patients. 82% of the patients have been treated by concomitant hormotherapy. For the 74 Gy level of dose, 50% of the patients have an ilio-obturator curage and 84% received concomitant hormotherapy. Radiotherapy post-prostatectomy has been done for 7 patients. The subject of the discussion is the respect of Standardized Good Practices as defined in Luxemburg.


CONCLUSIONS
The national strategy instaured since September 2000 has been respected. The Urologists are invited to transmit post-radiotherapy toxicities to the clinical research associate. EORTC 22991 protocol is now initiated. The aim of this study is to demonstrate that combining three-dimensional conformal radiotherapy and adjuvant hormonotherapy can increase survival and reduce metastatic progression risk in localized prostate cancer (T1, T2).
Untereiner
Michel
M
Centre François Baclesse, Centre National de Radiothérapie, rue Emile Mayrisch, BP 436, L-4005, Esch/Alzette.
Mecellem
Hinda
H
Triviere
Nicolas
N
Ruchaud
Romain
R
Joseph
Stéphane
S
Podolak
Nathalie
N
D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D011878:Radiotherapy / Q000009:adverse effects; D012189:Retrospective Studies; D016896:Treatment Outcome